Jonathan Violin

Jonathan Violin was the founder of Trevena, Inc. (founded in 2007) where he held the title of Senior Director-Investor & Media Relations from 2015 to 2018.
He is also the founder of Quellis Biosciences LLC (founded in 2017) where he held the title of Director in 2021.
Dr. Violin is also the founder of Dianthus Therapeutics OpCo, Inc. Dr. Violin's current job is as the Chief Executive Officer & Co-Manager at Viridian LLC.
He is also currently an Independent Director at Astria Therapeutics, Inc. and a Director at Dianthus Therapeutics, Inc. Dr. Violin's former job was as the President, Chief Executive Officer & Director at Viridian Therapeutics, Inc. from 2020 to 2023.
Dr. Violin's education includes an undergraduate degree from Duke University, a doctorate degree from the University of California San Diego, and an MBA from The Fuqua School of Business.